Previous 10 | Next 10 |
Image source: The Motley Fool. ICU Medical, inc (NASDAQ: ICUI) Q2 2021 Earnings Call Aug 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ICU Medical, inc (ICUI) Q2 2021 Earnings Call Transcript
ICU Medical (NASDAQ:ICUI): Q2 Non-GAAP EPS of $1.88 beats by $0.24; GAAP EPS of $1.31 beats by $0.09. Revenue of $321.7M (+6.0% Y/Y) beats by $11.67M. Press Release For further details see: ICU Medical EPS beats by $0.24, beats on revenue
SAN CLEMENTE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30,...
SAN CLEMENTE, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2021 earnings rel...
ICU Medical, Inc. (ICUI) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants John Mills – Managing Partner Vivek Jain – Chairman and Chief Executive Officer Brian Bonnell – Chief Financial Officer Conference Call Participants Matt Mishan – ...
Image source: The Motley Fool. ICU Medical Inc (NASDAQ: ICUI) Q1 2021 Earnings Call May 6, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ICU Medical Inc (ICUI) Q1 2021 Earnings Call Transcript
ICU Medical (ICUI): Q1 Non-GAAP EPS of $1.62 beats by $0.12; GAAP EPS of $1.09 beats by $0.01.Revenue of $318M (-3.2% Y/Y) beats by $12.93M.Press Release For further details see: ICU Medical EPS beats by $0.12, beats on revenue
SAN CLEMENTE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31,...
SAN CLEMENTE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2021 earnings rel...
SAN CLEMENTE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a v...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...